These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15755987)

  • 1. A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy.
    Wen PY
    Clin Cancer Res; 2005 Mar; 11(5):1685-6. PubMed ID: 15755987
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy.
    Davis ID; Kiers L; MacGregor L; Quinn M; Arezzo J; Green M; Rosenthal M; Chia M; Michael M; Bartley P; Harrison L; Daly M
    Clin Cancer Res; 2005 Mar; 11(5):1890-8. PubMed ID: 15756015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of chemotherapy-induced neuropathy: leukemia inhibitory factor.
    van den Bent MJ
    Clin Cancer Res; 2005 Mar; 11(5):1691-3. PubMed ID: 15755989
    [No Abstract]   [Full Text] [Related]  

  • 4. Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.
    Kautio AL; Haanpää M; Leminen A; Kalso E; Kautiainen H; Saarto T
    Anticancer Res; 2009 Jul; 29(7):2601-6. PubMed ID: 19596934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy.
    Argyriou AA; Chroni E; Polychronopoulos P; Iconomou G; Koutras A; Makatsoris T; Gerolymos MK; Gourzis P; Assimakopoulos K; Kalofonos HP
    Neurology; 2006 Dec; 67(12):2253-5. PubMed ID: 17190958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation.
    Argyriou AA; Chroni E; Koutras A; Iconomou G; Papapetropoulos S; Polychronopoulos P; Kalofonos HP
    J Pain Symptom Manage; 2006 Sep; 32(3):237-44. PubMed ID: 16939848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
    Amara S
    Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral neuropathy induced by oxaliplatin-based chemotherapy.
    J Support Oncol; 2006 Feb; 4(2):82-3. PubMed ID: 16499128
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripheral neuropathy related to chemotherapy.
    Wilkes G
    Semin Oncol Nurs; 2007 Aug; 23(3):162-73. PubMed ID: 17693343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral neuropathy: experimental findings, clinical approaches.
    J Support Oncol; 2007 Feb; 5(2):61-3. PubMed ID: 17354318
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy-induced peripheral neuropathy.
    Armstrong T; Almadrones L; Gilbert MR
    Oncol Nurs Forum; 2005 Mar; 32(2):305-11. PubMed ID: 15759068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
    Wolf S; Barton D; Kottschade L; Grothey A; Loprinzi C
    Eur J Cancer; 2008 Jul; 44(11):1507-15. PubMed ID: 18571399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib for the treatment of advanced renal cell carcinoma.
    Kane RC; Farrell AT; Saber H; Tang S; Williams G; Jee JM; Liang C; Booth B; Chidambaram N; Morse D; Sridhara R; Garvey P; Justice R; Pazdur R
    Clin Cancer Res; 2006 Dec; 12(24):7271-8. PubMed ID: 17189398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term glutamate supplementation failed to protect against peripheral neurotoxicity of paclitaxel.
    Loven D; Levavi H; Sabach G; Zart R; Andras M; Fishman A; Karmon Y; Levi T; Dabby R; Gadoth N
    Eur J Cancer Care (Engl); 2009 Jan; 18(1):78-83. PubMed ID: 19473225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial.
    Anselm IA; Darras BT
    Neurology; 2006 Oct; 67(7):1313; author reply 1313. PubMed ID: 17030784
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy-induced peripheral neuropathy: a new treatment option.
    Enck RE
    Am J Hosp Palliat Care; 2012 Nov; 29(7):509-11. PubMed ID: 23074287
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy-induced neuropathy.
    Rosson GD
    Clin Podiatr Med Surg; 2006 Jul; 23(3):637-49. PubMed ID: 16958394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. 1989.
    Cannon GW; Pincus SH; Emkey RD; Denes A; Cohen SA; Wolfe F; Saway PA; Jaffer AM; Weaver AL; Cogen L; Schindler JD
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S79-88. PubMed ID: 18240222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.
    Hausheer FH; Schilsky RL; Bain S; Berghorn EJ; Lieberman F
    Semin Oncol; 2006 Feb; 33(1):15-49. PubMed ID: 16473643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Put evidence into practice to treat chemotherapy-induced peripheral neuropathy.
    Oestreicher P
    ONS Connect; 2007 Dec; 22(12):24-5. PubMed ID: 18161384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.